Holen Sie sich die Stockscreener-App
11.93
7.96%
0.88
Handel nachbörslich:
11.90
-0.03
-0.25%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TNDM?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$11.05
Offen:
$11.18
24-Stunden-Volumen:
2.17M
Relative Volume:
1.16
Marktkapitalisierung:
$806.10M
Einnahmen:
$796.00M
Nettoeinkommen (Verlust:
$-136.49M
KGV:
-5.7081
EPS:
-2.09
Netto-Cashflow:
$-64.24M
1W Leistung:
+10.26%
1M Leistung:
-22.08%
6M Leistung:
-61.52%
1J Leistung:
-71.92%
1-Tages-Spanne:
$11.16
$12.08
1-Wochen-Bereich:
$10.25
$12.08
52-Wochen-Spanne:
$9.98
$47.60
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Firmenname
Tandem Diabetes Care Inc
Sektor
Branche
Telefon
858-366-6900
Adresse
12400 HIGH BLUFF DRIVE, San Diego, CA
Vergleichen Sie TNDM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
11.93 | 732.45M | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-06-16 | Eingeleitet | Truist | Hold |
| 2025-04-10 | Eingeleitet | Mizuho | Neutral |
| 2025-03-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-03-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | Eingeleitet | Bernstein | Outperform |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-10-02 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-22 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-08-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-30 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-05-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-04-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | Hochstufung | Stifel | Hold → Buy |
| 2023-08-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-05-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-04-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-11-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-08-09 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | Eingeleitet | Wells Fargo | Overweight |
| 2020-07-31 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-07-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-06-18 | Bestätigt | Raymond James | Outperform |
| 2020-04-24 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-06 | Eingeleitet | Raymond James | Outperform |
| 2020-02-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | Eingeleitet | Guggenheim | Buy |
| 2019-10-04 | Hochstufung | UBS | Neutral → Buy |
| 2019-05-17 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-13 | Eingeleitet | SVB Leerink | Outperform |
| 2019-03-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-03-05 | Bestätigt | BofA/Merrill | Neutral |
| 2019-02-27 | Bestätigt | Lake Street | Buy |
| 2018-11-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | Bestätigt | Dougherty & Company | Buy |
| 2018-09-26 | Bestätigt | Piper Jaffray | Overweight |
Alle ansehen
Tandem Diabetes Care Inc Aktie (TNDM) Neueste Nachrichten
Sirius XM, Lovesac, Rogers, Tandem Diabetes, and Altice Shares Are Falling, What You Need To Know - Yahoo Finance
Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say - MSN
Tandem Diabetes: Lowering Our Fair Value Estimate Significantly on Signs of Softness - Morningstar
Commercial and Competitive Headwinds to Delay Tandem's Shift to Positive Profits - Morningstar
Diabetes warning issued over insulin pump error - MSN
Tandem Diabetes Care Inc. Forms Bullish Flag — Upside AheadJuly 2025 Setups & Fast Moving Market Watchlists - metal.it
Software correction coming for faulty insulin pumps - MSN
Why Tandem Diabetes Care Inc. stock attracts strong analyst attentionJuly 2025 Rallies & Weekly High Return Forecasts - thegnnews.com
What is Tandem Diabetes Care Inc.’s valuation compared to sector - kangso.co.kr
What’s the recovery path for long term holders of Tandem Diabetes Care Inc. - Newser
Will Tandem Diabetes Care Inc. continue its uptrendCPI Data & Weekly Return Optimization Plans - Newser
Reversal indicators forming on Tandem Diabetes Care Inc. stockStop Loss & Free Weekly Watchlist of Top Performers - Newser
Technical analysis overview for Tandem Diabetes Care Inc. stockMarket Performance Recap & Growth Oriented Trading Recommendations - Newser
Trend analysis for Tandem Diabetes Care Inc. this week2025 Earnings Impact & Weekly Top Gainers Trade List - Newser
PNC Financial Services Group Inc. Sells 3,004 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - Defense World
Relative strength of Tandem Diabetes Care Inc. in sector analysisRate Hike & High Accuracy Buy Signal Tips - Newser
Analyzing drawdowns of Tandem Diabetes Care Inc. with statistical toolsWeekly Volume Report & Capital Protection Trade Alerts - Newser
Price momentum metrics for Tandem Diabetes Care Inc. explainedTrade Volume Report & Weekly Return Optimization Alerts - Newser
What makes Tandem Diabetes Care Inc. stock price move sharplyOptions Play & High Accuracy Trade Signal Alerts - Newser
What does recent volatility data suggest for Tandem Diabetes Care Inc.July 2025 Action & Free Long-Term Investment Growth Plans - Newser
Watch for Bullish Crossover in Tandem Diabetes Care Inc.July 2025 Weekly Recap & Accurate Trade Setup Notifications - sundaytimes.kr
Published on: 2025-08-15 18:45:11 - kangso.co.kr
Tandem Diabetes upgraded at Citi on risk-reward setup - MSN
Will Tandem Diabetes Care Inc. outperform the marketJuly 2025 Technicals & Technical Pattern Alert System - Newser
Tandem Diabetes Care’s SWOT analysis: stock faces challenges amid competitive pressures - Investing.com Australia
Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm - The Globe and Mail
Tandem Diabetes Care, Inc. (TNDM) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - The Globe and Mail
FDA Warns of Dangerous Error in Popular Insulin Pump Linked to 700 Adverse Events - Prevention
Intraday Charts Show Spike in Tandem Diabetes Care Inc. ActivityDay Trade & High Win Rate Trade Tips - thegnnews.com
FDA clearances: Imris, Daxor Corp., Tandem Diabetes Care - Modern Healthcare
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Given Consensus Rating of “Hold” by Brokerages - Defense World
Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The Globe and Mail
Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know - Yahoo Finance
Diabetes Warning Issued Over Insulin Pump Error - Newsweek
Tandem Diabetes Care: Strategic Growth Potential and Market Expansion Drive Buy Rating - TipRanks
5 Insightful Analyst Questions From Tandem Diabetes’s Q2 Earnings Call - Yahoo Finance
Published on: 2025-08-13 16:11:40 - 선데이타임즈
Lake Street Capital Downgrades Tandem Diabetes Care (NASDAQ:TNDM) to Hold - Defense World
Tandem Diabetes Care: Navigating Volatility and Innovation in a Polarized Market - AInvest
Tandem Diabetes' Recent Surge: Is This the Start of a Long-Term Rally or a Short-Lived Rebound? - AInvest
Tandem Diabetes Care Shares Rise After Upgrade From Citigroup - MarketScreener
Tandem Diabetes upgraded to Neutral by Citi, citing shift in risk-reward setup - AInvest
Tandem Diabetes stock upgraded at Citi (TNDM:NASDAQ) - Seeking Alpha
Tandem Diabetes at Canaccord Conference: Strategic Shifts and Market Focus - Investing.com Canada
Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know - Yahoo Finance
Tandem Diabetes Care shares rise 7.46% intraday after Citigroup upgrades stock to Neutral. - AInvest
Tandem Diabetes Care Stock (TNDM) Opinions on Q2 2025 Earnings Miss - Quiver Quantitative
Citigroup Upgrades Tandem Diabetes Care to Neutral From Sell, Adjusts Price Target to $10.35 From $10 - MarketScreener
Citi Upgrades Tandem Diabetes Care to Neutral, Raises PT to $10.35 - AInvest
TNDM Q2 Deep Dive: Margin Pressures and Strategic Shifts Offset Sales Growth - ca.finance.yahoo.com
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 6.6% on Analyst Downgrade - Defense World
Finanzdaten der Tandem Diabetes Care Inc-Aktie (TNDM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tandem Diabetes Care Inc-Aktie (TNDM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Morrison Susan | EVP & Chief Admin. Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,600 |
0 |
39,376 |
| Sheridan John F | PRESIDENT & CEO |
Aug 15 '25 |
Option Exercise |
0.00 |
11,453 |
0 |
115,001 |
| Carpenter Rick | Chief Technology Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,335 |
0 |
22,824 |
| Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Aug 15 '25 |
Option Exercise |
0.00 |
2,998 |
0 |
36,258 |
| Hansen Shannon Marie | EVP & Chief Legal Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
3,065 |
0 |
19,102 |
| Gasser Elizabeth Anne | EVP, Chief Strategy Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,600 |
0 |
1,795 |
| Sheridan John F | PRESIDENT & CEO |
Aug 11 '25 |
Buy |
10.23 |
10,000 |
102,318 |
106,327 |
| Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Aug 08 '25 |
Buy |
10.89 |
13,720 |
149,404 |
25,580 |
| Kyrillos Jean-Claude | EVP & Chief Operating Officer |
Jul 15 '25 |
Option Exercise |
0.00 |
14,545 |
0 |
25,254 |
| Carpenter Rick | Chief Technology Officer |
Jun 16 '25 |
Option Exercise |
0.00 |
406 |
0 |
21,426 |
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):